Sponsor:
St. Jude Children's Research Hospital
Code:
NCT06289673
Conditions
Acute Lymphoblastic Leukemia
Lymphoblastic Lymphoma
Mixed Phenotype Acute Leukemia
Eligibility Criteria
Sex: All
Age: 1 - 18
Healthy Volunteers: Not accepted
Interventions
Dexamethasone
Vincristine
Daunorubicin
Intrathecal triple therapy (methotrexate + hydrocortisone + cytarabine)
Methotrexate
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-02. This information was provided to ClinicalTrials.gov by St. Jude Children's Research Hospital on 2025-03-26.